Hologram QSAR studies on farnesoid X receptor activators (2006)
Source: Letters in Drug Design and Discovery. Unidade: IFSC
Subjects: QUÍMICA MÉDICA, FÁRMACOS, HOLOGRAMAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HONÓRIO, Káthia Maria e GARRATT, Richard Charles e POLIKARPOV, Igor. Hologram QSAR studies on farnesoid X receptor activators. Letters in Drug Design and Discovery, v. 3, n. 4, p. 261-267, 2006Tradução . . Acesso em: 15 nov. 2024.APA
Honório, K. M., Garratt, R. C., & Polikarpov, I. (2006). Hologram QSAR studies on farnesoid X receptor activators. Letters in Drug Design and Discovery, 3( 4), 261-267.NLM
Honório KM, Garratt RC, Polikarpov I. Hologram QSAR studies on farnesoid X receptor activators. Letters in Drug Design and Discovery. 2006 ; 3( 4): 261-267.[citado 2024 nov. 15 ]Vancouver
Honório KM, Garratt RC, Polikarpov I. Hologram QSAR studies on farnesoid X receptor activators. Letters in Drug Design and Discovery. 2006 ; 3( 4): 261-267.[citado 2024 nov. 15 ]